{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:27:25Z","timestamp":1762100845562},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1007\/s11940-008-0049-2","type":"journal-article","created":{"date-parts":[[2008,11,26]],"date-time":"2008-11-26T15:25:08Z","timestamp":1227713108000},"page":"468-474","source":"Crossref","is-referenced-by-count":17,"title":["Use of oral contraceptives and postmenopausal hormone replacement: Evidence on risk of stroke"],"prefix":"10.1007","volume":"10","author":[{"given":"Patricia H.","family":"Davis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,25]]},"reference":[{"key":"49_CR1","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S1550-8579(06)80214-7","volume":"3","author":"S.M. Harman","year":"2006","unstructured":"Harman SM: Estrogen replacement in menopausal women: recent and current prospective studies, the WHI and the KEEPS. Gend Med 2006, 3:254\u2013269.","journal-title":"Gend Med"},{"key":"49_CR2","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S1474-4422(05)70220-9","volume":"4","author":"C.D. Bushnell","year":"2005","unstructured":"Bushnell CD: Oestrogen and stroke in women: assessment of risk. Lancet Neurol 2005, 4:743\u2013751.","journal-title":"Lancet Neurol"},{"key":"49_CR3","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1440-1681.2007.04683.x","volume":"34","author":"S.P. Duckles","year":"2007","unstructured":"Duckles SP, Krause DN: Cerebrovascular effects of oestrogen: multiplicity of action. Clin Exp Pharmacol Physiol 2007, 34:801\u2013808.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"49_CR4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2174\/157016108783955338","volume":"6","author":"A. Billeci","year":"2008","unstructured":"Billeci A, Paciaroni M, Caso V, Agnelli G: Hormone replacement therapy and stroke. Curr Vasc Pharmacol 2008, 6:112\u2013123.","journal-title":"Curr Vasc Pharmacol"},{"key":"49_CR5","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/1933719107303673","volume":"14","author":"M.E. Wierman","year":"2007","unstructured":"Wierman ME, Kohrt WM: Vascular and metabolic effects of sex steroids: new insights into clinical trials. Reprod Sci 2007, 14:300\u2013314.","journal-title":"Reprod Sci"},{"key":"49_CR6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/01.gme.0000177906.94515.ff","volume":"13","author":"J.E. Manson","year":"2006","unstructured":"Manson JE, Bassuk SS, Harman S, et al.: Postmenopausal hormone therapy: new questions and the case for new clinical trials. Menopause 2006, 13:139\u2013147.","journal-title":"Menopause"},{"issue":"Suppl1","key":"49_CR7","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1016\/j.genm.2008.03.009","volume":"5","author":"V.M. Miller","year":"2008","unstructured":"Miller VM, Jayachandran M, Hashimoto K, et al.: Estrogen, inflammation, and platelet phenotype. Gend Med 2008, 5(Suppl 1):S91\u2013S102.","journal-title":"Gend Med"},{"key":"49_CR8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/humupd\/dml028","volume":"12","author":"The ESHRE Capri Workshop Group","year":"2006","unstructured":"The ESHRE Capri Workshop Group: Hormones and cardiovascular health in women. Hum Reprod Update 2006, 12:483\u2013497.","journal-title":"Hum Reprod Update"},{"key":"49_CR9","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/gme.0b013e31802e8508","volume":"14","author":"H.N. Hodis","year":"2007","unstructured":"Hodis HN, Mack WJ: Postmenopausal hormone therapy in clinical perspective. Menopause 2007, 14:944\u2013957.","journal-title":"Menopause"},{"key":"49_CR10","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.STR.0000015345.61324.3F","volume":"33","author":"J.M. Kemmeren","year":"2002","unstructured":"Kemmeren JM, Tanis BC, van den Bosch MA, et al.: Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke. Stroke 2002, 33:1202\u20131208.","journal-title":"Stroke"},{"key":"49_CR11","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.annemergmed.2007.05.001","volume":"51","author":"D.G. Stein","year":"2008","unstructured":"Stein DG, Wright DW, Kellermann AL: Does progesterone have neuroprotective properties? Ann Emerg Med 2008, 51:164\u2013172.","journal-title":"Ann Emerg Med"},{"key":"49_CR12","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/archinte.164.7.741","volume":"164","author":"W.S. Chan","year":"2004","unstructured":"Chan WS, Ray J, Wai EK, et al.: Risk of stroke in women exposed to low-dose oral contraceptives: a critical evaluation of the evidence. Arch Intern Med 2004, 164:741\u2013747.","journal-title":"Arch Intern Med"},{"key":"49_CR13","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1210\/jc.2004-1958","volume":"90","author":"J.P. Baillargeon","year":"2005","unstructured":"Baillargeon JP, McClish DK, Essah PA, Nestler JE: Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis. J Clin Endocrinol Metab 2005, 90:3863\u20133870.","journal-title":"J Clin Endocrinol Metab"},{"key":"49_CR14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/jama.284.1.72","volume":"284","author":"L.A. Gillum","year":"2000","unstructured":"Gillum LA, Mamidipudi SK, Johnston SC: Ischemic stroke risk with oral contraceptives: a meta-analysis. JAMA 2000, 284:72\u201378.","journal-title":"JAMA"},{"key":"49_CR15","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1161\/STROKEAHA.107.488395","volume":"38","author":"L.R. MacClellan","year":"2007","unstructured":"MacClellan LR, Giles W, Cole J, et al.: Probable migraine with visual aura and risk of ischemic stroke: The Stroke Prevention in Young Women Study. Stroke 2007, 38:2438\u20132445.","journal-title":"Stroke"},{"key":"49_CR16","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/j.1538-7836.2005.01442.x","volume":"3","author":"A.J. Slooter","year":"2005","unstructured":"Slooter AJ, Rosendaal FR, Tanis BC, et al.: Prothrombotic conditions, oral contraceptives, and the risk of ischemic stroke. J Thromb Haemost 2005, 3:1213\u20131217.","journal-title":"J Thromb Haemost"},{"key":"49_CR17","first-page":"844","volume":"91","author":"I. Martinelli","year":"2006","unstructured":"Martinelli I, Battaglioli T, Burgo I, et al.: Oral contraceptive use, thrombophilia and their interaction in young women with ischemic stroke. Haematologica 2006, 91:844\u2013847.","journal-title":"Haematologica"},{"key":"49_CR18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/jnnp.2006.101675","volume":"78","author":"A. Pezzini","year":"2007","unstructured":"Pezzini A, Grassi M, Iacoviello L, et al.: Inherited thrombophilia and stratification of ischaemic stroke risk among users of oral contraceptives. J Neurol Neurosurg Psychiatry 2007, 78:271\u2013276.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"49_CR19","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1182\/blood-2007-08-110254","volume":"111","author":"D.M. Pruissen","year":"2008","unstructured":"Pruissen DM, Slooter AJ, Rosendaal FR, et al.: Coagulation factor XIII gene variation, oral contraceptives, and risk of ischemic stroke. Blood 2008, 111:1282\u20131286.","journal-title":"Blood"},{"key":"49_CR20","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/00006250-200606000-00055","volume":"107","author":"ACOG Committee on Practice Bulletins-Gynecology","year":"2006","unstructured":"ACOG Committee on Practice Bulletins-Gynecology: ACOG practice bulletin. No. 73: Use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol 2006, 107:1453\u20131472.","journal-title":"Obstet Gynecol"},{"key":"49_CR21","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1161\/01.STR.0000223048.70103.F1","volume":"37","author":"L.B. Goldstein","year":"2006","unstructured":"Goldstein LB, Adams R, Alberts MJ, et al.: Primary prevention of ischemic stroke: a guideline from the American Heart Association\/American Stroke Association Stroke Council. Stroke 2006, 37:1583\u20131633.","journal-title":"Stroke"},{"key":"49_CR22","first-page":"e25","volume":"117","author":"W. Rosamond","year":"2008","unstructured":"Rosamond W, Flegal K, Furie K, et al.: Heart disease and stroke statistics\u20142008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008, 117:e25\u2013e146.","journal-title":"Circulation"},{"key":"49_CR23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1055\/s-2006-933316","volume":"26","author":"C.D. Bushnell","year":"2006","unstructured":"Bushnell CD: Hormone replacement therapy and stroke: the current state of knowledge and directions for future research. Semin Neurol 2006, 26:123\u2013130.","journal-title":"Semin Neurol"},{"key":"49_CR24","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa010534","volume":"345","author":"C.M. Viscoli","year":"2001","unstructured":"Viscoli CM, Brass LM, Kernan WN, et al.: A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med 2001, 345:1243\u20131249.","journal-title":"N Engl J Med"},{"key":"49_CR25","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1161\/CIRCULATIONAHA.105.594077","volume":"113","author":"S.L. Hendrix","year":"2006","unstructured":"Hendrix SL, Wassertheil-Smoller S, Johnson KC, et al.: Effects of conjugated equine estrogen on stroke in the Women\u2019s Health Initiative. Circulation 2006, 113:2425\u20132434.","journal-title":"Circulation"},{"key":"49_CR26","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","volume":"291","author":"The Women\u2019s Health Initiative Steering Committee","year":"2004","unstructured":"The Women\u2019s Health Initiative Steering Committee: Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women\u2019s Health Initiative Randomized Controlled Trial. JAMA 2004, 291:1701\u20131712.","journal-title":"JAMA"},{"key":"49_CR27","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.289.20.2673","volume":"289","author":"S. Wassertheil-Smoller","year":"2003","unstructured":"Wassertheil-Smoller S, Hendrix S, Limacher M, et al., for the WHI Investigators: Effect of estrogen plus progestin on stroke in postmenopausal women: The Women\u2019s Health Initiative: a randomized trial. JAMA 2003, 289:2673\u20132684.","journal-title":"JAMA"},{"key":"49_CR28","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.297.13.1465","volume":"297","author":"J.E. Rossouw","year":"2007","unstructured":"Rossouw JE, Prentice RL, Manson JE, et al.: Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007, 297:1465\u20131477.","journal-title":"JAMA"},{"key":"49_CR29","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1056\/NEJMoa071513","volume":"356","author":"J.E. Manson","year":"2007","unstructured":"Manson JE, Allison MA, Rossouw JE, et al.: Estrogen therapy and coronary-artery calcification. N Engl J Med 2007, 356:2591\u20132602.","journal-title":"N Engl J Med"},{"key":"49_CR30","doi-asserted-by":"crossref","first-page":"E28","DOI":"10.1371\/journal.pctr.0020028","volume":"2","author":"C. Kooperberg","year":"2007","unstructured":"Kooperberg C, Cushman M, Hsia J, et al.: Can biomarkers identify women at increased stroke risk? The Women\u2019s Health Initiative Hormone Trials. PLoS Clin Trials 2007, 2:E28.","journal-title":"PLoS Clin Trials"},{"key":"49_CR31","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/bmj.38331.655347.8F","volume":"330","author":"P.M.W. Bath","year":"2005","unstructured":"Bath PMW, Gray LJ: Association between hormone replacement therapy and subsequent stroke: a meta-analysis. BMJ 2005, 330:342.","journal-title":"BMJ"},{"key":"49_CR32","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/jama.299.9.1036","volume":"299","author":"G. Heiss","year":"2008","unstructured":"Heiss G, Wallace R, Anderson GL, et al.: Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA 2008, 299:1036\u20131045.","journal-title":"JAMA"},{"key":"49_CR33","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/archinte.168.8.861","volume":"168","author":"F. Grodstein","year":"2008","unstructured":"Grodstein F, Manson JE, Stampfer MJ, Rexrode K: Postmenopausal hormone therapy and stroke: role of time since menopause and age at initiation of hormone therapy. Arch Intern Med 2008, 168:861\u2013866.","journal-title":"Arch Intern Med"},{"issue":"3Suppl","key":"49_CR34","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.18553\/jmcp.2008.14.S3-A.14","volume":"14","author":"E.M. Umland","year":"2008","unstructured":"Umland EM: Treatment strategies for reducing the burden of menopause-associated vasomotor symptoms. J Manag Care Pharm 2008, 14(3 Suppl):S14\u2013S19.","journal-title":"J Manag Care Pharm"},{"key":"49_CR35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/ncpneuro0686","volume":"4","author":"C.D. Bushnell","year":"2008","unstructured":"Bushnell CD: Stroke and the female brain. Nat Clin Pract Neurol 2008, 4:22\u201333.","journal-title":"Nat Clin Pract Neurol"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-008-0049-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-008-0049-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-008-0049-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T08:08:20Z","timestamp":1632384500000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-008-0049-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["49"],"URL":"https:\/\/doi.org\/10.1007\/s11940-008-0049-2","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}